SG2918 For Advanced Malignant Tumors

NCT06167486 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: SG2918

Sponsor

Hangzhou Sumgen Biotech Co., Ltd.